Showing results (161-170 of 430) with videos related to
Sort By:
Pageof 43
Journal of the American College of Cardiology|May 10, 2008
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or bothL Michael Prisant, Kevin L Thomas, Eldrin F Lewis, et al.Lancet (London, England)|August 18, 2009
Albuminuria in chronic heart failure: prevalence and prognostic importanceColette E Jackson, Scott D Solomon, Hertzel C Gerstein, et al.Circulation|October 7, 2004
Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) programScott D Solomon, Duolao Wang, Peter Finn, et al.Diabetes Care|July 11, 2022
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker StudyHertzel C Gerstein, Sibylle Hess, Brian Claggett, et al.Journal of the American College of Cardiology|February 19, 2013
Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery diseaseTorbjørn Omland, Marc A Pfeffer, Scott D Solomon, et al.Journal of the American College of Cardiology|July 17, 2007
Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE TrialTorbjørn Omland, Marc S Sabatine, Kathleen A Jablonski, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 6, 2021
Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HFThor Ueland, Lars Gullestad, Lei Kou, et al.European Journal of Heart Failure|May 23, 2026
Cardiovascular events after acute myocardial infarction complicated by low ejection fraction and/or congestion: a landmark analysis of the PARADISE-MI trialJacinthe Boulet, Jean-Lucien Rouleau, Mark Petrie, et al.European Journal of Heart Failure|January 26, 2022
Natriuretic peptide-based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON-HFMaria A Pabón, Jonathan W Cunningham, Brian L Claggett, et al.European Heart Journal|October 27, 2009
Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trialJonathan P Piccini, Min Zhang, Karen Pieper, et al.Pageof 43